Status:
TERMINATED
Improving Sexual Health in Gynecologic Cancer Patients
Lead Sponsor:
Case Comprehensive Cancer Center
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study seeks to find out if an early intervention of providing directed sexual health education and treatment for gynecologic cancer patients will improve patient outcomes as compared to routine c...
Detailed Description
Participants will be randomly placed to one of two groups. This random placement allows our research study to be more significant when the study team checks the results. In one group, the "control" gr...
Eligibility Criteria
Inclusion
- Able to consent
- Screening positive for sexual health dysfunction as per baseline FSFI
- Diagnosed with any gynecologic malignancy
- It is acceptable to have received treatment prior to or during enrollment, including prior surgery, chemotherapy, radiation, hormonal therapy, or clinical trial.
Exclusion
- Unable to speak English
- Patients unable to consent
Key Trial Info
Start Date :
July 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03827993
Start Date
July 22 2019
End Date
June 15 2022
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44195